Company Overview and News

 
Market Update: Hindalco, Vedanta jump 7% as CNX Metal outperforms; UltraTech, Yes Bank top gainers

2018-04-19 moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 29 points was trading at 10,555 while the Sensex was up 63 points or 0.18 percent.
Upvote Downvote

 
Market Update: Metal stocks outshine as NALCO, Hindustan Copper jump 9-12%; HUL hits new 52-week high

2018-04-19 moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 33 points was trading at 10,560 while the Sensex was up 65 points or 0.19 percent.
Upvote Downvote

 
Market Update: CNX metal outperforms led by Hindustan Copper; TCS trades in green, Hindalco jumps 4%

2018-04-19 moneycontrol
The Indian equity market was trading on a positive note on Thursday morning with the Nifty gaining 28 points was trading at 10,554 while the Sensex was up 76 points or 0.22 percent.
Upvote Downvote

 
Market Update: FMCG, realty space outperforms led by Godrej Properties, ITC; Infosys, ICICI most active

2018-04-18 moneycontrol
The Indian equity market was trading flat on Wednesday afternoon with the Nifty marginally up and was trading at 10,554 while the Sensex was up 26 points or 0.08 percent.
Upvote Downvote

 
Market Update: Nifty Pharma gains led by Cipla, Divi#39;s Labs; Zee Entertainment up 2%, DHFL most active

2018-04-18 moneycontrol
The Indian equity market was trading flat on Wednesday morning with the Nifty marginally down and was trading at 10,548 while the Sensex was down 7 points.
Upvote Downvote

 
Market Update: Sensex, Nifty rebound as realty stocks outperform; HDFC Bank up 1%; Cipla top Nifty gainer

2018-04-16 moneycontrol
The Indian equity market was trading on a positive note on Monday afternoon with the Nifty adding 33 points and was trading above the 10,500 mark at 10,513 while the Sensex was up 95 points or 0.28 percent.
Upvote Downvote

 
Market Update: CNX IT remains weak as Infosys falls 3%; Tata Motors top loser, falls 5%, Idea at 52-week low

2018-04-16 moneycontrol
The Indian equity market was trading on a negative note on Monday afternoon with the Nifty shedding 12 points and was trading just below the 10,500 mark at 10,468 while the Sensex was down 71 points or 0.21 percent.
Upvote Downvote

 
Market Update: CNX IT drags as Infosys falls 4%; SBI, ICICI Bank most active, Indiabulls Ventures zooms 16%

2018-04-16 moneycontrol
The Indian equity market was trading on a negative note on Monday morning with the Nifty shedding 13 points and was trading just below the 10,500 mark at 10,467 while the Sensex was down 57 points or 0.17 percent.
Upvote Downvote

 
Market Update: CNX Metal outshines as SAIL, JSPL gain over 3%; Infosys up 1% ahead of Q4

2018-04-13 moneycontrol
The Indian equity market continued trading on a positive note on Friday afternoon, with the Nifty up 21 points at 10,479 and the Sensex up 90 points, or 0.27 percent, at 34,202.
Upvote Downvote

 
Market Update: IT, Pharma index outperforms led by TCS, Glenmark; Adani Ports up 3%; SBI most active

2018-04-13 moneycontrol
The Indian equity market continued trading on a positive note on Friday afternoon with the Nifty adding 33 points and was trading just below the 10,500 mark at 10,491 while the Sensex was up 126 points or 0.37 percent.
Upvote Downvote

 
Market Update: Midcap index outperforms led by TVS Motor; Adani Ports top gainer, Escorts at new 52-week high

2018-04-13 moneycontrol
The Indian equity market was trading on a positive note on Friday morning with the Nifty adding 38 points and was trading just below the 10,500 mark at 10,497 while the Sensex was up 145 points or 0.43 percent.
Upvote Downvote

 
Pidilite Industries Limited - Change in Director(s)

2018-04-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Pidilite Industries Limited - ESOP/ESOS/ESPS

2018-04-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Pidilite Industries Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Market Update: CNX IT outperforms as TCS, HCL Tech trade higher; SBI, PNB drag PSU bank index lower

2018-04-11 moneycontrol
The Indian equity market was trading on a positive note on Wednesday afternoon with the Nifty adding 17 points at 10,419 mark while the Sensex was up 78 points or 0.23 percent.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 00B0JJV59